Get started
Author

Diana Maláriková

Observed names: D. Maláriková, Diana Malarikova, Malarikova, Diana, Maláriková, Diana
Institution: Charles University
ORCID: 0000-0002-3493-7833
Observed ORCID: 0000-0002-3493-7833
OpenAlex ID: A5044730076
Concurrent TP53 and CDKN2A Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy
2020 · Diana Malarikova, Adela Berkova, et al. · Cancers · 51
PDF
Sequencing‐based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy
2023 · J. Karolová, D. Kazantsev, et al. · American Journal of Hematology · 20
PDF
A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma
2020 · Ales Obr, Pavel Klener, et al. · British Journal of Haematology · 18
PDF
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
2022 · Radek Jakša, Jana Karolová, et al. · Laboratory Investigation · 10
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2022 · Ales Obr, Katerina Benesova, et al. · Annals of Hematology · 5
PDF
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
2024 · Diana Malarikova, Radek Jorda, et al. · Experimental Hematology and Oncology · 2
PDF
Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BH3-Mimetics in Experimental Models of Relapsed/Refractory Mantle Cell Lymphoma
2022 · Diana Malarikova, Radek Jorda, et al. · Blood · 2
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
2025 · Prokop Vodicka, Yucai Wang, et al. · Blood · 1
BCL-XL Blockage with A1155463 Significantly Increases Efficacy of Venetoclax in Mantle Cell Lymphoma in Vitro and In Vivo
2022 · Alexandra Dolníková, Dmitry Kazantsev, et al. · Blood · 1
Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BCL2 Inhibitor Venetoclax in Experimental Models of Chemotherapy Refractory Mantle Cell Lymphoma
2021 · Diana Malarikova, Radek Jorda, et al. · Blood · 1
Comorbidity burden and prognosis in patients aged 80+ years with large B-cell lymphoma
2026 · Prokop Vodička, Michal Masár, et al. · Clinical Lymphoma Myeloma & Leukemia
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone (CHEPA) in newly diagnosed CD30-positive peripheral T-cell lymphomas with integrated ctDNA analysis: Results of the phase 2 CHEPA trial.
2026 · Marek Trněný, Pavel Klener, et al. · Journal of Clinical Oncology
PDF
Predictive performance of the LEO comorbidity index in patients aged 80+ years with large B-cell lymphoma
2025 · Prokop Vodicka, Michal Masar, et al. · Blood
PDF
Age-stratified prognostic performance of patient- vs disease-related IPI factors in large B-cell lymphoma
2025 · Prokop Vodicka, Matthew Maurer, et al. · Blood
Treatment patterns in patients aged 80+ years with LBCL: Propensity score analysis reveals comparable outcomes between R-CHOP and R-mini-CHOP
2025 · Prokop Vodicka, Patrick Reagan, et al. · Blood
PDF
Outcomes of T-cell/histocyte-rich large B-cell lymphoma (THRLBCL): An international LEO/MER and NiHiL collaborative study
2025 · Juan Alderuccio, Prokop Vodička, et al. · Blood
PDF
Fundamental prognostic difference of ATM gene mutation and deletion in newly diagnosed mantle cell lymphoma
2025 · Ales Obr, Diana Malarikova, et al. · Molecular Medicine
PDF
Study of molecular mechanisms and pathophysiological aspects of aggressive lymphoma therapy focused on targeted apoptosis induction and/or cell cycle inhibition
2025 · Maláriková, Diana · Digital Repository (National Repository of Grey Literature)
Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care?
2024 · Liliana Tuskova, Diana Maláriková, et al. · Blood
PDF
Comprehensive Genomic Analysis of Non-Relapsed and Late-Relapsed Mantle Cell Lymphoma Patients Compared to Refractory and Early-Relapsed Patients Treated By Standard Immunochemotherapy
2024 · Jana Karolova, Dmitry Kazantsev, et al. · Blood
PDF
BMI and Its Changes As a Predictor of Survival in DLBCL Patients
2024 · Michal Masar, Prokop Vodicka, et al. · Blood
PDF
Experimental model of primary intraocular lymphoma based on BALB/CaNn strain and A20 cells is optimal for investigational research
2024 · Eva Skrlova, Eva Uherkova, et al. · Biomedical Papers
PDF
Promising preclinical efficacy of intravitreally administered tafasitamab and anti‐Hu CD199 on immunocompetent murine model of primary intraocular lymphoma
2024 · Eva Skrlova, Eva Uherkova, et al. · Acta Ophthalmologica
Type of Atm Aberration Has a Different Impact on Survival Parameters in Mantle Cell Lymphoma
2023 · A. Obr, D. Maláriková, et al. · Hematological Oncology
PDF
Comparison of two primary intraocular lymphoma experimental murine models
2022 · Eva Skrlova, Eva Uherkova, et al. · Acta Ophthalmologica
Works count: 30
Citation count: 111
H-index: 5
I10-index: 4
Year
Topic
Type